| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.1M | +182.6% |
| Cost of Revenue | $1.5M | +145.5% |
| Gross Profit | $1.6M | +227.9% |
| R&D Expense | $59.6M | -11.0% |
| SG&A Expense | $50.5M | +13.2% |
| Operating Income | -$108.6M | +2.3% |
| Pre-tax Income | -$101.0M | -5.2% |
| Income Tax | $56K | — |
| Net Income | -$101.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.2M | -63.2% |
| Accounts Receivable | $1.3M | +262.2% |
| Inventory | $4.1M | +3.1% |
| Current Assets | $218.0M | -18.1% |
| Total Assets | $247.9M | -16.9% |
| Current Liabilities | $18.2M | +56.7% |
| Total Liabilities | $32.5M | +21.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.8M | +6.6% |
| Capital Expenditures | $4.6M | +1.6% |
| Investing Cash Flow | -$32.7M | -122.8% |
| Financing Cash Flow | $35.9M | — |
| Free Cash Flow | -$92.4M | +6.3% |
| -5.3% |
| EPS (Basic) | -$0.71 | -4.4% |
| EPS (Diluted) | -$0.71 | -4.4% |
| Stockholders' Equity |
| $215.4M |
| -20.7% |